About: Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific journal article

Attributes	Values
rdf:type	Item
description	artículu científicu espublizáu en 2012 (ast) vědecký článek publikovaný v roce 2012 (cs) 2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած (hyw) 2012 թվականի փետրվարին հրատարակված գիտական հոդված (hy) наукова стаття, опублікована в лютому 2012 (uk) مقالة علمية (نشرت في فبراير 2012) (ar) wetenschappelijk artikel (gepubliceerd op 2012/02/01) (nl) vedecký článok (publikovaný 2012/02/01) (sk) article publié dans la revue scientifique Nature (fr) scientific journal article (en) im Februar 2012 veröffentlichter wissenschaftlicher Artikel (de) artykuł naukowy opublikowany w Nature 1 lutego 2012 (pl)
publication date	wds:Q28512778-487972F0-7036-4FC1-A9DA-2650EA975C6F
publication date	2012-02-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q28512778-3602AE12-C5B3-47A4-9D36-FB6C558DA797
language of work or name	English
cites work	wds:Q28512778-01DBAAEF-EE64-4258-88E3-513C1D51EF24 wds:Q28512778-0202BCB2-53E5-4880-88A1-66D8CB20F654 wds:Q28512778-0BC6B36B-7408-476C-BB36-C299891A8C87 wds:Q28512778-1361DD74-0856-4F05-BDC7-F1D7F37C8706 wds:Q28512778-15DB6380-85C9-4DB9-AF03-5FF991841AAD wds:Q28512778-1D8F7C57-7CBF-40B7-811B-2E2B10CA5ACB wds:Q28512778-22E378D2-AE2B-47B4-B9C5-2B192C0E326D wds:Q28512778-2ECE1B17-92C3-4607-A5B2-B8470CFF9C8C wds:Q28512778-37802AC6-47DC-43AB-A944-DD4E9BA6430D wds:Q28512778-40D9226F-0C1E-498F-B8B2-E68187322141 wds:Q28512778-44353974-C09A-46C6-B55A-2AC30483BE52 wds:Q28512778-513D89A2-D620-4DF8-9B5D-1BBB1EF360B0 wds:Q28512778-550F9B75-7E64-45DE-B44D-24A1EA19D938 wds:Q28512778-5619922B-1A33-427B-B6A0-7AD3176AFA2B wds:Q28512778-5BC9C0E2-4E3E-44BB-A4D8-337002819378 wds:Q28512778-68F7CF3D-4E00-48BD-B6AB-31D3C5A4190B wds:Q28512778-73F16E2D-6EC8-437C-BDA4-68A29D70C45E wds:Q28512778-74752CDA-BBC1-4E45-93D0-D227659F6824 wds:Q28512778-7FEA7959-1292-48E4-A555-8EB8F548944D wds:Q28512778-81AFE2C1-1D73-4BE8-883B-AD1914373E15 wds:Q28512778-81BBA723-21A1-4272-888F-D6E3C7A62785 wds:Q28512778-877E6648-A2D7-459F-8A86-BC3AB57733BD wds:Q28512778-8D0498DD-9D7E-4153-A5ED-B6F79B702C10 wds:Q28512778-9B11F46B-0ABA-4CB9-A4A5-8209B82E4574 wds:Q28512778-9D621143-15F4-40A3-ACEC-BB810CA08296 wds:Q28512778-A04B3408-788C-4370-8A30-817AE31598EF wds:Q28512778-A83BD8AE-3B96-41E6-B894-34A9B00E8E18 wds:Q28512778-AAFD2029-62F6-4DA4-B85F-578E84969B50 wds:Q28512778-AD832BD0-EC23-4D47-ADA1-870AF350E6D1 wds:Q28512778-B3ED79ED-2F49-4A62-A4A2-DD35CDC02BC9 wds:Q28512778-BCEFBB9C-3813-4EC1-B2A1-9DD362D60900 wds:Q28512778-BF4023FD-173F-4C1E-A0D8-07110C3F7E99 wds:Q28512778-C4A5086A-1DC2-45DB-95BD-BC089046A13E wds:Q28512778-D4B1D6DD-C270-4513-904E-D02CB5B44BB0 wds:Q28512778-DC7B9E93-1866-442A-9347-9705A20A3585 wds:Q28512778-E1025847-80C9-4CE4-ACDA-BCC735F590EF wds:Q28512778-F0794020-8B13-4485-ADB0-039674E0D286 wds:Q28512778-F3159509-1DEC-41B0-A2D7-FE1A7734DB8A wds:Q28512778-F83F24AE-7834-462A-BCEF-0C51B47E6F09 wds:Q28512778-F907AFDE-79C5-4358-9B39-E734145F6E98 wds:Q28512778-FF177E61-7442-4670-A39D-DB9F94517BE1
cites work	Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis A Toll-like receptor recognizes bacterial DNA Prognosis in nonalcoholic steatohepatitis Thioredoxin-interacting protein links oxidative stress to inflammasome activation Design and validation of a histological scoring system for nonalcoholic fatty liver disease NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance Gut flora and bacterial translocation in chronic liver disease Inflammasome is a central player in the induction of obesity and insulin resistance Linkage of gut microbiome with cognition in hepatic encephalopathy Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder Nonalcoholic Steatohepatitis Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities TLR4 enhances TGF-beta signaling and hepatic fibrosis Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance Cirrhosis and liver failure in nonalcoholic fatty liver disease: Molehill or mountain? QIIME allows analysis of high-throughput community sequencing data Relationship of Porphyromonas gingivalis with glycemic level in patients with type 2 diabetes following periodontal treatment. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1 A role for mitochondria in NLRP3 inflammasome activation Steatohepatitis: a tale of two "hits"? Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage Lessons from animal models of NASH Leptin signaling in intestinal epithelium mediates resistance to enteric infection by Entamoeba histolytica Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease The inflammasome in pathogen recognition and inflammation Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome Non-alcoholic steatohepatitis and animal models: understanding the human disease. Liver histology and follow up of 68 patients with ulcerative colitis and normal liver function tests Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease The role of leptin in progression of non-alcoholic fatty liver disease Nonalcoholic fatty liver disease
author name string	wds:Q28512778-236D401F-9032-49D9-8780-1D2CE716D0B7

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software